Galvani Bioelectronics is a pioneering research and development company dedicated to bringing bioelectronic therapies to patients. The company was formed through a partnership between two global healthcare companies, GSK and Verily Life Sciences, a subsidiary of Alphabet Inc. Galvani is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.